For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260327:nRSa5110Ya&default-theme=true
RNS Number : 5110Y CT Healthcare Trust PLC 27 March 2026
CT Healthcare Trust plc
("the Company")
(Formerly Bellevue Healthcare Trust plc)
Notice of Annual General Meeting 2026
The Company announces that its Notice of Annual General Meeting 2026 (the
'Notice') is available to view on the Company's website:
www.columbiathreadneedle.co.uk/ct-healthcare-trust/document-centre/
(http://www.columbiathreadneedle.co.uk/ct-healthcare-trust/document-centre/)
The Company's Annual General Meeting 2026 will be held at the offices of Hogan
Lovells International LLP, Atlantic House, Holborn Viaduct, London EC1A 2FG on
28 April 2026 at 12 noon.
A copy of the Notice has been posted to those shareholders who have requested
to receive hard copy documents and is available for inspection at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)
Change of Auditor
Following a competitive tender process, led by the Company's Audit and Risk
Committee, the Board has approved the appointment of BDO LLP ("BDO") as the
Company's new external auditor. A resolution to approve the appointment of BDO
will be proposed at the Company's Annual General Meeting.
Ernst & Young LLP ("EY") has ceased to be the Company's auditor and has
confirmed to the Company that there are no matters connected with its ceasing
to hold office that need to be brought to the attention of the members or
creditors of the Company for the purposes of section 519 of the Companies Act
2006.
The Company wishes to thank EY for their services over the years and their
continued support.
Enquiries:
NSM Funds (UK) Limited
Company Secretary
+44 (0) 20 3697 5770
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOABLGDXRXDDGLR
Copyright 2019 Regulatory News Service, all rights reserved